These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 433624)

  • 21. Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.
    Buice RG; Evans WE; Karas J; Nicholas CA; Sidhu P; Straughn AB; Meyer MC; Crom WR
    Clin Chem; 1980 Dec; 26(13):1902-4. PubMed ID: 7002366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassay for 2-methoxyoestrone in human plasma.
    Emons G; Ball P; von Postel G; Knuppen R
    Acta Endocrinol (Copenh); 1979 May; 91(1):158-66. PubMed ID: 452826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of cyanocobalamin in serum by a specific radioimmunoassay.
    Rothenberg SP; Marcoullis GP; Schwarz S; Lader E
    J Lab Clin Med; 1984 Jun; 103(6):959-72. PubMed ID: 6726060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radioligand assay: method and application. II. Effect of glucagon coupling on the production of glucagon antisera with suitable binding parameters for radioimmunoassay].
    Ziegler M; Keilacker H; Woltanski KP; Besch W; Schubert J
    Acta Biol Med Ger; 1980; 39(2-3):305-14. PubMed ID: 6775484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Techniques for the measurement of methotrexate in biological samples.
    Aherne GW; Quinton M
    Cancer Treat Rep; 1981; 65 Suppl 1():55-60. PubMed ID: 7326665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of 2,4-diamino-N10-methylpteroic acid after high-dose methotrexate.
    Donehower RC; Hande KR; Drake JC; Chabner BA
    Clin Pharmacol Ther; 1979 Jul; 26(1):63-72. PubMed ID: 445963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sensitive and specific radioimmunoassay for LY309887, a potent inhibitor of glycinamide ribonucleotide formyltransferase.
    Coleman DL; Canak N; Place GD; Shih C; Bowsher RR
    Clin Cancer Res; 1998 Jan; 4(1):157-63. PubMed ID: 9516965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of anti-GM4 antiserum and its assay by a solid-phase radioimmunoassay.
    Jacobson RI; Kasai N; Richards FF; Yu RK
    J Neuroimmunol; 1982 Nov; 3(3):225-35. PubMed ID: 7142381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
    Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
    Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related pharmacokinetics of high-dose methotrexate in patients with osteosarcoma.
    Wang YM; Sutow WW; Romsdahl MM; Perez C
    Cancer Treat Rep; 1979 Mar; 63(3):405-10. PubMed ID: 284845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioimmunoassay of nicergoline in biological material.
    Bizollon CA; Rocher JP; Chevalier P
    Eur J Nucl Med; 1982; 7(7):318-21. PubMed ID: 7117274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting.
    Gargosky SE; Pham HM; Wilson KF; Liu F; Giudice LC; Rosenfeld RG
    Endocrinology; 1992 Dec; 131(6):3051-60. PubMed ID: 1280211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
    Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
    Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunoassay for the testosterone 5 alpha-reductase inhibitor turosteride in biological fluids.
    Persiani S; Broutin F; Pianezzola E; Panzeri A; Fonte G; Fontana E; Strolin Benedetti M
    J Immunoassay; 1994 May; 15(2):97-113. PubMed ID: 8040353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate].
    Etienne MC; Thyss A; Bertrand Y; Rubie H; Milano G
    Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].
    Janka GE; Wiesner H; Bidlingmaier F; Haas RJ
    Klin Wochenschr; 1979 Apr; 57(8):411-6. PubMed ID: 313478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and application of a specific and sensitive radioimmunoassay for trihexyphenidyl to a pharmacokinetic study in humans.
    He H; McKay G; Wirshing B; Midha KK
    J Pharm Sci; 1995 May; 84(5):561-7. PubMed ID: 7658345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
    Perez C; Wang YM; Sutow WW; Herson J
    Cancer Clin Trials; 1978; 1(2):107-11. PubMed ID: 316368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bumetanide: radioimmunoassay and pharmacokinetic profile in humans.
    Dixon WR; Young RL; Holazo A; Jack ML; Weinfeld RE; Alexander K; Liebman A; Kaplan SA
    J Pharm Sci; 1976 May; 65(5):701-4. PubMed ID: 932937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-presssure liquid chromatographic determination of methotrexate and its major metabolite, 7-hydroxymethotrexate, in human plasma.
    Watson E; Cohen JL; Chan KK
    Cancer Treat Rep; 1978 Mar; 62(3):381-7. PubMed ID: 647697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.